Eight Minutes to Best Practice on Effective Implementation & Integration of Disposables (Single-Use) Systems
Disposables (Single-Use) systems have been widely established in pharmaceutical and biotechnology companies’ biomanufacturing processes across Europe and the US with proven economic and fast product changeover benefits. Tony Hitchcock, Head of Manufacturing Technologies at Cobra Biologics explains best practices on implementation and integration of multi-component disposable systems, maximising economic benefits and utilising new biomanufacturing models.
In this exclusive interview Alain Pralong, VP New Product Introduction and Technical Life Cycle Management at GlaxoSmithKline Vaccines, speaks about the challenges faced evaluating single-use systems for extractables and leachables and implementing single-use technology in biopharmaceutical manufacturing.
In this Pharma IQ interview Tony Hitchcock, Technical Director at Cobra Biologics, speaks to Andrea Charles from Pharma IQ, about why single use systems are not implemented more commonly across the biomanufacturing industry and the challenges surrounding scale up.
Desmond Hunt, Senior Scientific Liaison, United States Pharmacopoeia (USP), discusses the current standards and guidance for single-use systems and the expectations for the new chapter from the USP regarding single-use systems. Hunt also shares his insights on challenges for extractables and leachables.